These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35822241)

  • 1. Increased
    Park SJ; Frake RA; Rubinsztein DC
    Autophagy; 2023 Mar; 19(3):943-944. PubMed ID: 35822241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinexin contributes to autophagic decline in brain ageing across species.
    Park SJ; Frake RA; Karabiyik C; Son SM; Siddiqi FH; Bento CF; Sterk P; Vicinanza M; Pavel M; Rubinsztein DC
    Cell Death Differ; 2022 May; 29(5):1055-1070. PubMed ID: 34848853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
    Pavel M; Park SJ; Tanasa R; Rubinsztein DC
    Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An amphipathic helix of vinexin α is necessary for a substrate stiffness-dependent conformational change in vinculin.
    Hino N; Ichikawa T; Kimura Y; Matsuda M; Ueda K; Kioka N
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30578314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development.
    Astone M; Lai JKH; Dupont S; Stainier DYR; Argenton F; Vettori A
    Sci Rep; 2018 Jul; 8(1):10189. PubMed ID: 29976931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.
    Edwards AC; Stalnecker CA; Jean Morales A; Taylor KE; Klomp JE; Klomp JA; Waters AM; Sudhakar N; Hallin J; Tang TT; Olson P; Post L; Christensen JG; Cox AD; Der CJ
    Cancer Res; 2023 Dec; 83(24):4112-4129. PubMed ID: 37934103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
    Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
    J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
    Nagashima S; Bao Y; Hata Y
    Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases.
    Li R; Huang W
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optogenetic method for interrogating YAP1 and TAZ nuclear-cytoplasmic shuttling.
    Dowbaj AM; Jenkins RP; Williamson D; Heddleston JM; Ciccarelli A; Fallesen T; Hahn KM; O'Dea RD; King JR; Montagner M; Sahai E
    J Cell Sci; 2021 Jul; 134(13):. PubMed ID: 34060624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of smooth muscle YAP and TAZ in protection against phenotypic modulation, inflammation, and aneurysm development.
    Daoud F; Arévalo Martínez M; Holst J; Holmberg J; Albinsson S; Swärd K
    Biochem Pharmacol; 2022 Dec; 206():115307. PubMed ID: 36270325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt16 Promotes Vascular Smooth Muscle Contractile Phenotype and Function via Taz (Wwtr1) Activation in Male LDLR-/- Mice.
    Behrmann A; Zhong D; Li L; Xie S; Mead M; Sabaeifard P; Goodarzi M; Lemoff A; Kozlitina J; Towler DA
    Endocrinology; 2023 Dec; 165(2):. PubMed ID: 38123514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma.
    Liu L; Lu Z; Hu X; Su T; Su L; Pu H
    Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinculin promotes nuclear localization of TAZ to inhibit ECM stiffness-dependent differentiation into adipocytes.
    Kuroda M; Wada H; Kimura Y; Ueda K; Kioka N
    J Cell Sci; 2017 Mar; 130(5):989-1002. PubMed ID: 28115535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.
    Strnadel J; Choi S; Fujimura K; Wang H; Zhang W; Wyse M; Wright T; Gross E; Peinado C; Park HW; Bui J; Kelber J; Bouvet M; Guan KL; Klemke RL
    Cancer Res; 2017 Apr; 77(8):1997-2007. PubMed ID: 28381547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
    Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
    J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.